Certainly worth repeating zoomboom's 12/31/12 post (#33612) about share structure response from Gerald:
Quote: -------------------------------------------------- Yes Gerald replied yesterday to an Email i sent him on the 28th.
he is a little busy preparing for the conference but he did reply.
this is what he wrote: "We will be updating the entire market regarding the share structure in the appropriate time. The most recent 10Q has the most up-to-date information available to the market. The Company maintains that it has not entered into any additional financing transactions since the last 10Q, the Company has not sold any shares and none of the officers or directors have sold any shares. Given the data that is upcoming, the officers and directors are precluded from buying shares in the marketplace at this time until the data is released, as that is material non-public information.
Am 27. November 2012, geändert Amarantus Biosciences, Inc. ihren Namen Amarantus Bioscience, Inc. Dies wurde auf einem vorher rechtzeitig eingereicht 8-K angegeben. Am 2. Januar Amarantus die Mitteilung, dass DTCC wird die Veränderung Namen Amarantus Bioscience, Inc. am 3. Januar 2013 zu verarbeiten.
Ich werde das Gefühl nicht los, das Amarantus hier eine Bärenfalle vom feinsten vorbereitet! Gerald hat sich in der Vergangenheit mal sehr negativ über die Short Attacken geäußert! Wenn jetzt noch eine Hammer News in den Markt gestreut wird, dann sollte es sogar gelingen!
* Approximately 379 Million Shares Shorted Since June 2011 * Short Squeeze Continues As Stock Above $0.0484 SqueezeTrigger Price
NEWPORT BEACH, Calif., Jan. 3, 2013 (GLOBE NEWSWIRE) -- BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has updated coverage on Amarantus BioSciences (OTCBB:AMBS) after releasing the latest short sale data through January 2, 2013. The total aggregate number of shares shorted since June 2011 is approximately 379 million shares. Approximately 28.88% of daily trading volume is short selling. The SqueezeTrigger price for all AMBS shares shorted is $0.0484. A short squeeze is well underway as stock is above its SqueezeTrigger Price.
Friction Factor calculates if a fair market is being made in the shares of AMBS. 54% of the previous 37 trading days have been positive or bullish-biased and 46% have been negative or bearish-biased.
Regulation SHO requires bona-fide market-making activities to include making purchases and sales in roughly comparable amounts. The Commission has stated that bona-fide market-making DOES NOT include activity that is related to speculative selling strategies or investment purposes of the broker-dealer and is disproportionate to the usual market making patterns or practices of the broker-dealer in that security. Likewise, where a market-maker posts continually at or near the best offer, but does not also post at or near the best bid, the market-maker's activities would not generally qualify as bona-fide market-making. Moreover, a market-maker that continually executes short sales away from its posted quotes would generally not be considered to be engaging in bona-fide market-making.
BUYINS.NET monitors AMBS market-makers daily for compliance with Fair Market-Making Requirements.
About BUYINS.NET
BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies and comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.
INVESTMENTS & TRADING
SqueezeTrigger -- 36 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. AMBS has paid $1,116 per month to purchase data to be provided in six monthly reports. AMBS has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.
nicht pennen würde könnte man nachkaufen! erst das zeug anbieten und dann nichts unter kontrolle zum kotzen! meine alten anteile sind seit 3 wochen nicht handelbar! das ist kein zustand.
Thread abonnieren
